Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|July 27, 2024
Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune DiseasesRanjeet Singh Mahla, Esther L Jones, Lynn B DustinAntimicrobial Agents and Chemotherapy|August 8, 2012
Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cellsMohsan Saeed, Troels K H Scheel, Judith M Gottwein, et al.Gastroenterology|May 1, 2017
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From InterferonsStephen M Laidlaw, Svetlana Marukian, Rachel H Gilmore, et al.Journal of Virology|February 15, 2005
Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infectionThomas J Chambers, Xiaofeng Fan, Deborah A Droll, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patientsJianhua Ni, Edgardo Hembrador, Adrian M Di Bisceglie, et al.Obesity (Silver Spring, Md.)|December 7, 2018
Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 StudyEdgar D Charles, Brent A Neuschwander-Tetri, Juan Pablo Frias, et al.Clinical and Translational Science|September 1, 2023
Pharmacokinetics, safety, and tolerability of BMS-986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairmentHisham Qosa, Claudia H M C de Oliveira, Giovanni Cizza, et al.JHEP Reports : Innovation in Hepatology|January 3, 2022
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitisYi Luo, Benjamin E Decato, Edgar D Charles, et al.Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)Michael J Fuller, Benoit Callendret, Baogong Zhu, et al.Hepatology (Baltimore, Md.)|December 7, 2011
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cellsLinda Andrus, Svetlana Marukian, Christopher T Jones, et al.Pageof 6